Skip to main content
Staff Login
Username
*
Enter your The Contraceptive Pipeline Database username.
Password
*
Enter the password that accompanies your username.
Log in
Forgot password
Toggle navigation
ENG Pellets
Product Overview
Development Status:
Active Development
Target:
Female
Mode:
Hormonal
Delivery Type:
Subdermal
Duration Type:
Long-acting
Description:
A biodegradable implant that can achieve 18 months duration using etonogestrel /cholesterol fused pellets.
Updated date:
May 30, 2018
Vertical Tabs
Product Details
Active Pharmaceutical Ingredient (API):
etonogestrel
Inactive material:
Cholesterol
Potential Multi-Purpose Technology (MPT):
No
Duration:
18 months
Partner:
GeSea Biosciences
,
FHI 360
,
pH Sciences
Status
Project Phase:
Early Development
Project Stage:
Pre-clinical
Began discovery in:
2015
Status Details:
Builds upon earlier work on NET Pellets with Anterion Therapeutics.
Programmatic Considerations
Considerations:
No need for removal.
Additional Information
Additional Information:
FHI 360 website
Footnotes:
See also entry on NET Pellets.
Download Product Report
